Raul Nogueira, MD
Vascular Neurology · Pittsburgh, PANPI 1912975921
Payments from drug & device makers
Across 297 payments — averaging $22,843 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medical Device Business Services, Inc.$5M
- Stryker$889K
- Corindus Inc.$478K
- Tulavi Therapeutics, Inc.$131K
- Perfuze Limited$115K
- Genentech, Inc.$46K
- plus $104K from 15 others
Across 2 payments — averaging $1979.68 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Biogen$4K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medical Device Business Services, Inc. | 110 | $5,021,046 |
| Stryker | 102 | $888,845 |
| Corindus Inc. | 5 | $477,799 |
| Tulavi Therapeutics, Inc. | 1 | $131,000 |
| Perfuze Limited | 5 | $115,352 |
| Genentech, Inc. | 3 | $46,100 |
| Neurovasc Technologies, Inc. | 3 | $31,664 |
| Medtronic(2 entities) | 18 | $20,043 |
| Phenox Inc. | 3 | $16,502 |
| Route 92 Medical, Inc. | 6 | $12,544 |
| Imperative Care, Inc | 5 | $6,252 |
| Biogen | 12 | $4,420 |
| Genentech USA, Inc. | 1 | $3,750 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $3,150 |
| Depuy Synthes Products, Inc. | 1 | $2,475 |
| Microvention, Inc. | 4 | $2,394 |
| Balt USA, LLC | 3 | $417 |
| Johnson & Johnson | 5 | $248 |
| Viz.ai, Inc. | 3 | $242 |
| Biosense Webster, Inc. | 2 | $142 |
| Penumbra, Inc. | 4 | $72 |
How this compares
$6,784,457 in reported general payments places this provider in the 95th percentile of 52 vascular neurology providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other vascular neurology in Pittsburgh
- Marcelo RochaPittsburgh$164K
- Alhamza Al-BayatiPittsburgh$134K
- Jussie Correia LimaPittsburgh$85K
- Neil SuryadevaraPittsburgh$9K
- Cynthia KenmuirPittsburgh$2K
- Liqi ShuPittsburgh$623
- Maryam ZulfiqarPittsburgh$526
- Murat SariPittsburgh$424
- Aaron Ravelo JimenezPittsburgh$418
- Elissa OrtolaniPittsburgh$349
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.